Methods
toxicity, cancer
CANCER
This section presents a general modeling framework and performance evaluation metrics for dose-finding designs that utilize continuous toxicity responses, which are widely applicable in the context of phase I cancer trials. Following this, we introduce a new fully Bayesian design aiming to estimate the MTD or an optimal dose under a specific setting where the dose-response curve is non-linear.